Latest Statin Stories
The Firm is currently representing clients in Lipitor lawsuits who allegedly developed new-onset Type 2 diabetes due to their use of the statin medication. New
Lipitor Lawsuits Pending In A Multidistrict Litigation In The U.S.
The Firm is currently representing numerous plaintiffs in Lipitor lawsuits that allege new-onset Type 2 diabetes caused by the cholesterol-lowering statin medication. New
Primary efficacy endpoints met in two trials of alirocumab administered every four weeks TARRYTOWN, N.Y. and PARIS, Jan. 9, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
The number of lawsuits alleging Lipitor diabetes complications continues to increase in the District of South Carolina, where a multidistrict litigation is underway. New
-- Revisions Include Sections on Suggested Limitations for Time Spent Being Sedentary, New BMI Cut Points for Screening Asian Americans for Diabetes and Guidance for Diabetes Screening During Pregnancy
The study's publication comes amid a growing number of Lipitor lawsuit filings on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of the cholesterol-lowering
More than 1,400 Lipitor lawsuits have been filed in federal court on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the statin medication. New
The study found that use of Lipitor and other statins may be tied to a significant increased risk for development of the ocular disorder. Port Washington, New
This study’s publication comes as hundreds of Lipitor lawsuit plaintiffs seek compensation for Type 2 diabetes they allegedly developed due to their use of the cholesterol-lowering statin.